Eagle Global Advisors’s Idexx Laboratories IDXX Stock Holding History

Eagle Global Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405K	Buy	770 +280	+57%	+$157K	0.01%	222
2026 Q1	$275K	Hold	490	–	–	0.01%	247
2025 Q4	$332K	Hold	490	–	–	0.01%	240
2025 Q3	$313K	Hold	490	–	–	0.01%	247
2025 Q2	$263K	Hold	490	–	–	0.01%	246
2025 Q1	$206K	Hold	490	–	–	0.01%	262
2024 Q4	$203K	Hold	490	–	–	0.01%	251
2024 Q3	$248K	Sell	490 -30	-6%	-$14.6K	0.01%	225
2024 Q2	$253K	Sell	520 -20	-4%	-$10K	0.01%	218
2024 Q1	$292K	Buy	540 +60	+13%	+$32.8K	0.02%	205
2023 Q4	$266K	Buy	+480	New	+$225K	0.02%	208

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Eagle Global Advisors's IDXX Position: Q2 2026 in Review

Eagle Global Advisors increased its Idexx Laboratories (IDXX) stake by 57% in Q2 2026, buying an estimated $157K and bringing the position to 770 shares worth $405K. The position accounts for 0.01% of the portfolio, ranked #222.

Eagle Global Advisors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Eagle Global Advisors held 770 shares of Idexx Laboratories worth $405K as of Q2 2026.
Eagle Global Advisors bought 280 Idexx Laboratories shares in Q2 2026, an estimated $157K.
Idexx Laboratories made up 0.01% of Eagle Global Advisors's portfolio in Q2 2026, its #222 holding.
Eagle Global Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Eagle Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.